JOHNSON & JOHNSON (JNJ)

US4781601046 - Common Stock

147.91  +2.17 (+1.49%)

After market: 147.91 0 (0%)

News Image
2 hours ago - InvestorPlace

These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

News Image
4 hours ago - Investor's Business Daily

Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review

The Nasdaq and S&P 500 tumbled below their 50-day lines.

News Image
6 hours ago - Yahoo Finance

Analyst updates Johnson & Johnson stock price target after earnings

This is what could happen next to Johnson & Johnson shares.

News Image
10 hours ago - Zacks Investment Research

The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron

NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron are included in this Analyst Blog.

News Image
a day ago - Yahoo Finance

J&J wins trial over Florida woman who claimed its baby powder caused her cancer

A Florida jury on Thursday concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida woman who died in 2019. The lawsuit was brought by family members of Patricia Matthey, a Sarasota County resident who used Johnson's baby powder daily from 1965 until August 2016, when she was diagnosed with ovarian cancer, according to her family's lawsuit. J&J's Worldwide Vice President of Litigation Erik Haas said the company was vindicated by the jury's decision.

News Image
a day ago - Zacks Investment Research

Top Stock Reports for NVIDIA, Alphabet & Johnson & Johnson

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ).

News Image
a day ago - InvestorPlace

Recession-Proof Riches: 3 Stocks That Thrive in Any Economy

Discover recession-proof stocks that thrive amid economic uncertainty, offering stability and consistent growth.

News Image
a day ago - InvestorPlace

Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.

Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.

News Image
2 days ago - InvestorPlace

Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough

Although monetary policy seemed to be moving in a dovish direction, a pivot may warrant a look at stocks for Fed hikes.

News Image
2 days ago - InvestorPlace

Put $10,000 in These 3 Dividend Stocks by 2025

In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income.

News Image
3 days ago - The Motley Fool

Why Johnson & Johnson Stock Got Tossed by the Market Today

A mixed quarter and narrowed guidance didn't really please investors.

News Image
3 days ago - Yahoo Finance

Why Johnson & Johnson Stock Got Tossed by the Market Today

A mixed quarter and narrowed guidance didn't really please investors.

News Image
3 days ago - The Motley Fool

Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript

JNJ earnings call for the period ending March 31, 2024.

News Image
3 days ago - Quartz

Johnson & Johnson's bet on heart devices boosted sales, but it still missed analysts expectations

The healthcare giant's stock fell 2% following its first quarterly earning report of the year

News Image
3 days ago - Yahoo Finance

Johnson & Johnson Q1 Earnings Top Wall Street Estimates On Strong Medical Devices Sales, Drugmaker Boosts Annual Outlook

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion. Operational growth was 3.9%, and adjusted operational growth was 4.0%. JNJ reported a net profit of $5.35 billion compared to a net loss of $(491) million a year ago, which included litigation charges of $6.9 billion. Innovative

News Image
3 days ago - InvestorPlace

JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024

JNJ stock results show that Johnson & Johnson beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image
3 days ago - Market News Video

Dow Movers: JNJ, UNH

News Image
3 days ago - Quartz

The Dow jumps 175 points as the markets look to break a losing streak

Bank of America, Morgan Stanley, and Johnson & Johnson all reported earnings before the bell, with United Airlines coming later

News Image
3 days ago - Yahoo Finance

Stock market today: Dow jumps 200 points as earnings roll in

Stocks eyed a broader comeback from a steep sell-off as investors digested results from Bank of America and other heavyweights.

News Image
15 days ago - Chartmill

Why NYSE:JNJ provides a good dividend, while having solid fundamentals.

Balancing Dividends and Fundamentals: The Case of JOHNSON & JOHNSON (NYSE:JNJ).